论文部分内容阅读
目的:探讨尸体肾移植术后人巨细胞病毒(HCMV)病的防治。方法:应用HCMVAg试验诊断HCMV感染。对本院实施的1150例尸体肾移植分两组进行回顾性分析。结果:治疗组:1989年9月～1997年4月共1050例,HCMV病45例,治愈30例,死亡15例;预防组:1997年5月～1998年5月,共100例,HCMV感染42例,由于进行了预防性治疗,无1例HCMV病发生和因HCMV感染而死亡。结论:HCMVAg试验可以早期诊断活动性HCMV感染,指导HCMV病的有效治疗;对活动性HCMV感染积极进行预防性治疗,能显著减少HCMV病的发生。
Objective: To investigate the prevention and treatment of human cytomegalovirus (HCMV) after cadaveric kidney transplantation. Methods: HCMV test was used to diagnose HCMV infection. A total of 1150 cadaveric renal transplantation patients in our hospital were retrospectively analyzed. Results: The treatment group: from September 1989 to April 1997 a total of 1050 cases, 45 cases of HCMV disease, cured 30 cases, 15 cases of death; prevention group: May 1997 ~ May 1998, a total of 100 cases of HCMV infection Forty-two patients died of one HCMV disease and one due to HCMV infection due to prophylactic treatment. Conclusion: The HCMVAg test can early diagnose active HCMV infection and guide the effective treatment of HCMV disease. Preventive treatment of active HCMV infection can significantly reduce the incidence of HCMV disease.